ClinicalTrials.Veeva

Menu

Decreasing Nightmares in Adults with Narcolepsy (DAWN)

Utah System of Higher Education (USHE) logo

Utah System of Higher Education (USHE)

Status

Not yet enrolling

Conditions

Nightmare Disorder with Associated Other Sleep Disorder
Nightmare
Narcolepsy Without Cataplexy
Narcolepsy with Cataplexy
Narcolepsy Type 1
Narcolepsy

Treatments

Behavioral: Imagery Rehearsal Therapy (IRT)

Study type

Interventional

Funder types

Other

Identifiers

NCT06383806
315-SR-23 (Other Grant/Funding Number)
IRB_00188162

Details and patient eligibility

About

The purpose of this clinical trial is learn whether a behavioral (non-medication) treatment can reduce nightmares in adults with narcolepsy. All participants will receive the treatment and will complete three assessments. Half of the participants will receive the treatment after the first assessment, and half will receive it after the second assessment.

Enrollment

40 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Diagnosis of narcolepsy type 1 or narcolepsy type 2
  • Nightmare frequency of ≥1 times per week
  • Age 18 or older
  • Able to speak, read, and write in English
  • Live in the United States
  • Sleep and medications stable for ≥ 1 month and willing to keep medications stable for the duration of the study

Exclusion criteria

  • Currently engaged in trauma- or sleep-related psychotherapy
  • Previous behavioral treatment for nightmares
  • Medical, psychiatric, or cognitive condition which would interfere with ability to engage in the treatment
  • Untreated moderate-severe sleep apnea

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

None (Open label)

40 participants in 2 patient groups

Treatment
Experimental group
Description:
The Treatment arm will receive the intervention immediately following the first assessment.
Treatment:
Behavioral: Imagery Rehearsal Therapy (IRT)
Waitlist
Other group
Description:
The Waitlist arm will undergo a waiting period following the first assessment and then will receive the treatment after the second assessment.
Treatment:
Behavioral: Imagery Rehearsal Therapy (IRT)

Trial contacts and locations

0

Loading...

Central trial contact

Jennifer Mundt, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems